Kevin Buehler - 25 Jun 2025 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Director
Signature: /s/ Dario Scimeca, Attorney-in-fact for Kevin Buehler
Issuer symbol: DTIL
Transactions as of: 25 Jun 2025
Net transactions value: +$21,116
Form type: 4
Filing time: 27 Jun 2025, 06:14:20 UTC
Previous filing: 04 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Buehler Kevin	Director	C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW ST, SUITE A-100, DURHAM	/s/ Dario Scimeca, Attorney-in-fact for Kevin Buehler	27 Jun 2025	0001792722

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Purchase	$21,116	+5,076	+22%	$4.16	28,137	25 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.16 to $4.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.16 to $4.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.